ART BioScience Israeli Company
ART BioScience specializes in the use of novel messenger RNA technologies for the development of therapeutics that may potentially change the course of Duchenne Muscular Dystrophy.
Health Tech & Life Sciences
Biotechnology
Medical
Therapeutics
Alternatives
No alternatives listed yet.
AI-Generated Alternatives
Powered by AI May contain mistakes
AI is thinking and generating alternatives...
{
$el.querySelectorAll('a').forEach(link => {
link.target = '_blank';
link.rel = 'noopener noreferrer';
});
})"
class="ai-alternatives-content prose prose-sm dark:prose-invert prose-headings:text-gray-900 dark:prose-headings:text-gray-100 prose-p:text-gray-700 dark:prose-p:text-gray-300 prose-strong:text-gray-900 dark:prose-strong:text-gray-100 max-w-none [&>h2]:mb-4 [&>h2]:mt-8 [&>h3]:mb-3 [&>h3]:mt-6 [&>p]:mb-4 [&>ul>li]:my-2 [&>ul]:space-y-3"
>
Suggest an Alternative
Office Locations
Rehovot, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/art-bioscience
[2]
crunchbase.com
- https://www.crunchbase.com/organization/art-bioscience
External links are provided for reference and verification purposes.